STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICU
  4. [8-K] SeaStar Medical Holding Corp Reports Material Event

SeaStar Medical (ICU) regains Nasdaq $1.00 minimum bid price compliance

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

SeaStar Medical Holding Corporation reported that it has regained compliance with Nasdaq’s minimum bid price requirement. On January 20, 2026, the company received confirmation from the Nasdaq Office of General Counsel that it once again meets the $1.00 minimum bid price standard set by Nasdaq Listing Rule 5550(a)(2). This means SeaStar Medical’s common stock and warrants continue to qualify for listing on The Nasdaq Stock Market, removing the immediate risk that its shares could be delisted solely for not meeting the bid price rule.

Positive

  • Regained Nasdaq minimum bid price compliance, removing an immediate risk of delisting related to Nasdaq Listing Rule 5550(a)(2).

Negative

  • None.

Insights

SeaStar Medical removes an immediate Nasdaq delisting risk by regaining the $1.00 bid price compliance.

SeaStar Medical Holding Corporation received confirmation on January 20, 2026 that it is back in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum $1.00 bid price. This indicates that, over the relevant measurement period, the company’s share price met or exceeded Nasdaq’s continued listing standard for bid price.

Maintaining compliance with this rule helps preserve the company’s listing of its common stock and warrants on The Nasdaq Stock Market. Continued Nasdaq listing typically supports trading liquidity and market visibility, compared with moving to a less prominent marketplace. Actual future impact will depend on how the share price behaves relative to Nasdaq’s standards over time.

Investors can now interpret the prior bid-price deficiency as resolved as of January 20, 2026, based on Nasdaq’s letter. Subsequent company disclosures will show whether SeaStar Medical maintains ongoing compliance with Nasdaq’s quantitative listing criteria and whether any new deficiencies arise.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
false 0001831868 0001831868 2026-01-20 2026-01-20 0001831868 icu:CommonStockCustomMember 2026-01-20 2026-01-20 0001831868 icu:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockFor1150PerShareCustomMember 2026-01-20 2026-01-20
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): January 20, 2026
 
SeaStar Medical Holding Corporation
 
(Exact name of Registrant as Specified in Its Charter)
 
 
 
Delaware
001-39927
85-3681132
(State or Other Jurisdiction
(Commission File Number)
(IRS Employer
of Incorporation)
  
Identification No.)
3513 Brighton Blvd,
    
Suite 410
    
Denver, Colorado
  
80216
(Address of Principal Executive Offices)
  
(Zip Code)
 
 
Registrant’s Telephone Number, Including Area Code: 844 427-8100
 
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
   
Trading
    
Title of each class
  
Symbol(s)
  
Name of each exchange on which registered
Common Stock par value $0.0001 per share
  
ICU
  
The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share
  
ICUCW
  
The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company ☒
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
 
 
Item 8.01.         Other Events
 
Regaining Compliance with the $1.00 Bid Price Rule
 
On January 20, 2026, the Company received a letter from the Nasdaq Office of General Counsel confirming that the Company has regained compliance with the minimum bid price requirement of the Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule").
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
SeaStar Medical Holding Corporation
   
By:
/s/ Eric Schlorff
Date:
January 20, 2026
Name:
Eric Schlorff
   
Title:
Chief Executive Officer
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Source: View Original Filing on SEC EDGAR

FAQ

What did SeaStar Medical Holding Corporation (ICU) disclose in this 8-K?

SeaStar Medical Holding Corporation disclosed that on January 20, 2026, it received a letter from the Nasdaq Office of General Counsel confirming it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

What is the Nasdaq minimum bid price rule mentioned for ICU?

The filing states that SeaStar Medical has regained compliance with the Nasdaq Listing Rule 5550(a)(2), referred to as the Minimum Bid Price Rule, which requires a minimum $1.00 bid price for continued listing on The Nasdaq Stock Market.

When did Nasdaq confirm SeaStar Medical’s compliance with the $1.00 bid price rule?

Nasdaq’s Office of General Counsel sent a letter dated January 20, 2026, confirming that SeaStar Medical had regained compliance with the $1.00 minimum bid price requirement.

Which SeaStar Medical securities are listed on Nasdaq?

The filing lists SeaStar Medical’s Common Stock, par value $0.0001 per share, trading under the symbol ICU, and its warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share, trading under the symbol ICUCW on The Nasdaq Stock Market LLC.

Why is regaining compliance with Nasdaq’s bid price rule important for ICU shareholders?

Regaining compliance with the $1.00 minimum bid price rule helps SeaStar Medical maintain its listing on The Nasdaq Stock Market, which can support trading liquidity and accessibility for shareholders compared with being moved off a major exchange.

Who signed the 8-K for SeaStar Medical Holding Corporation?

The report was signed on behalf of SeaStar Medical Holding Corporation by Eric Schlorff, who is identified as the company’s Chief Executive Officer.